Liu et al90 showed that MCCK1, a specific and effective IKKε inhibitor, enhanced the anticancer effect of temozolomide in glioblastoma, suggesting that IKKε was associated with chemotherapeutic resistance of glioblastoma. The gene discussed is IKBKE; the disease is glioblastoma.